Home > Newsletters > International Pharmaceutical Regulatory Monitor > India Outlines Stepwise Approach to Recalls, Rapid Alerts That Includes Trial Runs
International Pharmaceutical Regulatory Monitor
November 2012 | Vol. 40 No. 11
India Outlines Stepwise Approach to Recalls, Rapid Alerts That Includes Trial Runs
To ensure recall procedures are effective, makers of drugs, biologicals and vaccines must conduct a mock recall of at least one batch of any product and demonstrate the traceability of one of its raw materials, a draft guideline by India’s Central Drugs Standard Control Organization (CDSCO) says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.